Allan Camaisa - CEO and Chairman of the Board, Director, 10%+ Owner at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and Chairman of the Board, Director, 10%+ Owner
Stock Symbol
CLDI, CLDI-WT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Allan Camaisa since 10/5/2023

Holdings reported by Allan Camaisa for Calidi Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 76.7K $88.2K $1.15 Sep 26, 2024 Direct
Non-Qualified Stock Options (right to buy) 100K Dec 21, 2023 Direct Common stock
Stock Options (right to buy) 40K Jun 17, 2024 Direct Common stock $40K

Transactions reported by Allan Camaisa for Calidi Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.